{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000342.2:c.91A>C (p.Ala30Pro)",
          "cDNA Change": {
            "transcript": "NM_000342.2",
            "ref": "A",
            "alt": "C",
            "position": "91"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in a-synuclein"
        },
        {
          "HGVS": "NM_000342.2:c.158A>C (p.Ala53Thr)",
          "cDNA Change": {
            "transcript": "NM_000342.2",
            "ref": "A",
            "alt": "C",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in a-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0004789"
  },
  "Experiment Method": [
    {
      "Assay Method": "Microarray analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Neuroblastoma cells",
        "Description": "Neuroblastoma cell lines transfected with wild-type, A30P, or A53T a-synuclein"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000342.2:c.91A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered gene expression",
          "Result Description": "Significant downregulation of dopamine synthesis-related genes (GTP cyclohydrolase, sepiapterin reductase, tyrosine hydroxylase) in A30P and A53T transfectants"
        },
        {
          "Variant": "NM_000342.2:c.158A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered gene expression",
          "Result Description": "Significant downregulation of dopamine synthesis-related genes in A30P and A53T transfectants"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly stated"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly stated"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein transfection as control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection as control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Expression levels comparable to wild-type and empty vector controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly lower expression of dopamine synthesis genes compared to controls",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Quantitative RT-PCR",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Neuroblastoma cells",
        "Description": "Neuroblastoma cell lines transfected with wild-type, A30P, or A53T a-synuclein"
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000342.2:c.91A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered gene expression",
          "Result Description": "Confirmation of microarray results showing downregulation of dopamine synthesis genes in A30P transfectants"
        },
        {
          "Variant": "NM_000342.2:c.158A>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered gene expression",
          "Result Description": "Confirmation of microarray results showing downregulation of dopamine synthesis genes in A53T transfectants"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly stated"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly stated"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-synuclein transfection as control"
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector transfection as control"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Expression levels comparable to wild-type and empty vector controls",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significantly lower expression of dopamine synthesis genes compared to controls",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}